Susceptibility testing of Cryptococcus neoformans using the urea broth microdilution method. 1998

Y Nakamura, and R Kano, and S Watanabe, and H Takahashi, and A Hasegawa
Department of Dermatology, Teikyo University School of Medicine, Tokyo, Japan.

An urea broth microdilution method to assay the susceptibility of Cryptococcus neoformans to antifungal drugs was newly developed. Using this method, urease activity of the fungus was measured instead of the viability by checking colony development. The urease activities were indicated by colour changes in optical density at 545 nm. The end point in this assay was considered as 99% inhibitory concentration. When we measured antifungal activities of the three drugs against 16 isolates of Cr. neoformans using this assay method, mean minimum-inhibitory concentrations (MICs) of fluconazole, itraconazole and terbinafine were 2.0 micrograms ml-1, 0.008 microgram ml-1 and 0.25 microgram ml-1 respectively. This assay method resulted in higher sensitivity in MICs of the three antifungal drugs than the broth microdilution method recommended by the Committee for Laboratory Standards of the Japanese Society for Medical Mycology. The results obtained using this assay method support the more effective evaluation of antifungal substances in susceptibility testing of Cr. neoformans.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D003455 Cryptococcus neoformans A species of the fungus CRYPTOCOCCUS. Its teleomorph is Filobasidiella neoformans. Blastomyces neoformans,Debaryomyces neoformans,Filobasidiella neoformans,Lipomyces neoformans,Saccharomyces neoformans,Torula neoformans,Torulopsis neoformans,Cryptococcus neoformans var. grubii
D003470 Culture Media Any liquid or solid preparation made specifically for the growth, storage, or transport of microorganisms or other types of cells. The variety of media that exist allow for the culturing of specific microorganisms and cell types, such as differential media, selective media, test media, and defined media. Solid media consist of liquid media that have been solidified with an agent such as AGAR or GELATIN. Media, Culture
D000935 Antifungal Agents Substances that destroy fungi by suppressing their ability to grow or reproduce. They differ from FUNGICIDES, INDUSTRIAL because they defend against fungi present in human or animal tissues. Anti-Fungal Agents,Antifungal Agent,Fungicides, Therapeutic,Antibiotics, Antifungal,Therapeutic Fungicides,Agent, Antifungal,Anti Fungal Agents,Antifungal Antibiotics
D012680 Sensitivity and Specificity Binary classification measures to assess test results. Sensitivity or recall rate is the proportion of true positives. Specificity is the probability of correctly determining the absence of a condition. (From Last, Dictionary of Epidemiology, 2d ed) Specificity,Sensitivity,Specificity and Sensitivity
D014510 Urease An enzyme that catalyzes the conversion of urea and water to carbon dioxide and ammonia. EC 3.5.1.5. Phytourease,Urea Amidohydrolase,Amidohydrolase, Urea

Related Publications

Y Nakamura, and R Kano, and S Watanabe, and H Takahashi, and A Hasegawa
May 1996, Journal of clinical microbiology,
Y Nakamura, and R Kano, and S Watanabe, and H Takahashi, and A Hasegawa
November 1992, Journal of clinical microbiology,
Y Nakamura, and R Kano, and S Watanabe, and H Takahashi, and A Hasegawa
December 2014, Diagnostic microbiology and infectious disease,
Y Nakamura, and R Kano, and S Watanabe, and H Takahashi, and A Hasegawa
December 1997, Mycoses,
Y Nakamura, and R Kano, and S Watanabe, and H Takahashi, and A Hasegawa
December 2006, Journal of medical microbiology,
Y Nakamura, and R Kano, and S Watanabe, and H Takahashi, and A Hasegawa
April 1998, Journal of clinical microbiology,
Y Nakamura, and R Kano, and S Watanabe, and H Takahashi, and A Hasegawa
May 1993, Journal of clinical microbiology,
Y Nakamura, and R Kano, and S Watanabe, and H Takahashi, and A Hasegawa
June 2021, Antimicrobial agents and chemotherapy,
Y Nakamura, and R Kano, and S Watanabe, and H Takahashi, and A Hasegawa
February 2004, Memorias do Instituto Oswaldo Cruz,
Y Nakamura, and R Kano, and S Watanabe, and H Takahashi, and A Hasegawa
December 2000, The Journal of antimicrobial chemotherapy,
Copied contents to your clipboard!